Health Care/Hospital

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-01-03 08:00 3151

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across  North America, Asia, Europe and the Middle East NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ -- CathWorks, a global leader in medical device digital health innovations, announced today the successful completion of enrollment of t...

2025-01-03 02:30 1149

PieX AI: Launching the World's First Personalized, On-device AI Pendant at CES 2025

NEW YORK, Jan. 2, 2025 /PRNewswire/ -- PieX AI , a global leader in multimodal AI hardware for smart health, is set to proudly launch the world's first pendant featuring personalized, on-device AI at CES 2025. This innovative product aims to revolutionize mental health management...

2025-01-02 21:00 3147

HKSH Symposium on Advances in Cancer Management 2024 Breakthroughs in Cancer Management

HONG KONG, Jan. 2, 2025 /PRNewswire/ -- HKSH Cancer Centre organised the sixth "HKSH Symposium on Advances in Cancer Management" ("The Symposium") which was held on12 December 2024 at the HKSH Eastern Building. With the theme "Breakthroughs in Cancer Management", the Symposium attracted approxima...

2025-01-02 17:50 2729

HEALTH IN YOUR HANDS

The Rise of Home Testing for a Safer Future with AwarerHOME™ KUALA LUMPUR, Malaysia, Jan. 2, 2025 /PRNewswire/ -- HIV remains one of the most pressing health issues globally, yet for many, the conversation around it is still surrounded by discomfort and stigma. Despite advances in treatment and ...

2025-01-02 11:20 1620

Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate

SAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-01-02 07:30 4365

Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study

Further secures Brii's rights in BRII-179 with full control of intellectual property, future manufacturing and supply Several combination treatment studies containing BRII-179 have quickly started to carry forward the Company's strategy for HBV functional cure DURHAM, N.C. and BEIJING, Dec. 31, ...

2024-12-31 19:10 3289

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx (99mTc-iPSMA) have been published in the European ...

2024-12-31 04:45 2360

Orthodontics Meets Disney: Smartee Clear Aligners Brings Magic to Smiles

SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- Smartee Denti-Technology, a leading innovator in the orthodontics industry, is thrilled to announce the launch of its new Disney-licensed product - Smartee Ge Clear Aligner packages featuring Disney IP Mickey Mouse and Iron Man. These new aligners allow ort...

2024-12-30 18:38 3649

U.S.-based LifeWave Celebrates 20x Growth in 5 Years with New Kaohsiung Branch Opening

TAIPEI, Dec. 30, 2024 /PRNewswire/ -- Post-pandemic, global economies have faced numerous challenges. Yet, one company has defied the odds, achieving an astonishing 20-fold global revenue growth in just five years—from US$20 million to$400 million. LifeWave, the American direct-selling company, w...

2024-12-30 16:26 1764

Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer

SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) to initiate a Phase...

2024-12-30 13:28 4231

"Closing the Women's Health Gap - Highlights of Biotropics Malaysia clinical study by Women, on Women, for Women"

SHAH ALAM, Malaysia, Dec. 30, 2024 /PRNewswire/ -- While gender parity has seen progress in recent years, the women's health gap remains significant. Women, despite comprising half of the global labor force[1], often face under-diagnosis and under-representation in healthcare research. Biotropics...

2024-12-30 10:00 2810

Talent Satisfaction Elevated! YANNIGO Wins "Best Employee Retention Award" for its Dedication to Employee Well-being and a Happy Workplace

TAICHUNG, Dec. 30, 2024 /PRNewswire/ -- In today's competitive workplace, an organization's ability to retain talent has become a critical measure of its success and sustainable development. YANNIGO, a nutrition and wellness company headquartered in Taichung, was recently awarded the "2024 Best E...

2024-12-30 09:00 1781

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx...

2024-12-30 06:00 1856

Life-Space Wins Prestigious 62nd Australian Export Awards

MELBOURNE, Australia, Dec. 27, 2024 /PRNewswire/ -- At the prestigious 62nd Australian Export Awards held at Parliament House in Canberra, Life-Space, Australia's No. 1 probiotic brand, proudly claimed the title of 'E-commerce Winner of the Australian Export Awards 2024'. This incredible achievem...

2024-12-27 11:17 2314

Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference

ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that its Chairman and ...

2024-12-27 09:44 9257

VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology

PETALING JAYA, Malaysia, Dec. 27, 2024 /PRNewswire/ -- VISTA Eye Specialist (VISTA),Malaysia's leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study led by Dr. Aloysius Joseph Low, Medical Director and Ms. Azarina Abdullah, Optom...

2024-12-27 08:00 2394

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the ...

2024-12-26 19:00 1979

IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved

SUZHOU, China, Dec. 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulation consisting of anti-HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune ch...

2024-12-26 17:09 3933

Industry Partnership | Basecare Medical Group (2170.HK) and Jinghua Medical Group Sign Strategic Cooperation Agreement

SUZHOU, China, Dec. 25, 2024 /PRNewswire/ -- On December 24, 2024, Basecare Medical Group (2170.HK) held a strategic cooperation signing ceremony with Jinghua Medical Group inShenyang. Basecare Medical possesses a comprehensive technological platform covering andrology, embryo culture, genetics, ...

2024-12-25 11:03 4321
12345 ... 574